Molecular epidemiology of dengue virus type 3 in Venezuela.

During the past 40 years, dengue haemorrhagic fever and dengue shock syndrome (DHF/DSS) have emerged in humans, with approximately 3 million cases reported and over 58 000 deaths. Dengue virus serotypes 1, 2 and 4 (DENV-1, -2 and -4) have been co-circulating in Venezuela for at least the past 10 years, causing minor or major outbreaks of dengue fever (DF) and DHF/DSS. The first recorded outbreak due to DENV-3 in Venezuela dates to 1964 and the virus then seems to have disappeared. However, DENV-3 re-appeared recently (in July, 2000) in Venezuela after 32 years of absence and produced a prolonged major outbreak, which, by the end of 2001, involved 83 180 cases of dengue, mostly DF (92 %). Previous phylogenetic studies revealed that the DENV-3 circulating during the 1960s Latin American outbreak was a genotype V virus. To gain a better understanding of the nature of the current epidemic, the complete sequence was determined of the envelope (E) gene of 15 Venezuelan DENV-3 viruses isolated during 2000 and 2001 from patients presenting with different disease severity. Sequence data were used in phylogenetic comparisons with global samples of DENV-3. Analysis revealed that the strain circulating in Venezuela is closely related to isolates that were previously present in Panama and Nicaragua in 1994 and since then have spread through Central American countries and Mexico. This study also confirms previous reports showing that the DENV-3 strain currently circulating in the Americas is related to the strain that caused DHF epidemics in Sri Lanka and India in 1989-1991 (genotype III). Finally, no evidence of the re-emergence of the strain that circulated in Venezuela in the late 1960s and 1970s (genotype V) was found.

[1]  E. Holmes,et al.  Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. , 2002, Virology.

[2]  Edward C Holmes,et al.  Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus. , 2002, Virology.

[3]  E. Holmes,et al.  Molecular epidemiology of dengue type 2 virus in Venezuela: evidence for in situ virus evolution and recombination. , 2001, The Journal of general virology.

[4]  N. White,et al.  Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? , 2001, The Journal of infectious diseases.

[5]  H. Schatzmayr,et al.  Dengue virus type 3 in Rio de Janeiro, Brazil. , 2001, Memorias do Instituto Oswaldo Cruz.

[6]  S. Usuku,et al.  Phylogenetic analysis of dengue-3 viruses prevalent in Guatemala during 1996–1998 , 2001, Archives of Virology.

[7]  I. M. Rocco,et al.  First isolation of dengue 3 in Brazil from an imported case. , 2001, Revista do Instituto de Medicina Tropical de Sao Paulo.

[8]  L. Figueiredo,et al.  The Brazilian flaviviruses. , 2000, Microbes and infection.

[9]  M. P. Cummings,et al.  PAUP* Phylogenetic analysis using parsimony (*and other methods) Version 4 , 2000 .

[10]  Dengue in Central America: the epidemics of 2000. , 2000, Epidemiological bulletin.

[11]  E. Harris,et al.  Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. , 1999, The American journal of tropical medicine and hygiene.

[12]  D. Gubler,et al.  Impact of dengue/dengue hemorrhagic fever on the developing world. , 1999, Advances in virus research.

[13]  Fransisco P. Pinheiroa,et al.  Global situation of dengue and dengue haemorrhagic fever , and its emergence in the Americas , 1998 .

[14]  D. Gubler,et al.  Dengue and dengue hemorrhagic fever : Its history and resurgence as a global public health problem , 1997 .

[15]  Serological proficiency tests for dengue. , 1997, Epidemiological bulletin.

[16]  M. Guzmán,et al.  [Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas]. , 1996, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau.

[17]  Dengue type 3 infection--Nicaragua and Panama, October-November 1994. , 1995, MMWR. Morbidity and mortality weekly report.

[18]  R. Lanciotti,et al.  Molecular evolution and epidemiology of dengue-3 viruses. , 1994, The Journal of general virology.

[19]  D. Gubler,et al.  Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. , 1993, Infectious agents and disease.

[20]  R. Lanciotti,et al.  Phylogenetic relationships of dengue-2 viruses. , 1993, Virology.

[21]  D. Gubler,et al.  Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.

[22]  J. Oliver,et al.  The general stochastic model of nucleotide substitution. , 1990, Journal of theoretical biology.

[23]  R. Rico-Hesse,et al.  Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. , 1990, Virology.

[24]  Dengue hemorrhagic fever in Venezuela. , 1990, Epidemiological bulletin.

[25]  S. Halstead,et al.  Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. , 1989, Reviews of infectious diseases.

[26]  M. Guzmán,et al.  Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. , 1989, Bulletin of the World Health Organization.

[27]  J. Lennon Dengue in the Caribbean. , 1983, JAMA.